Is SCPS or MO a better dividend investment in 2026?

SCPS currently yields 500000.00% with a 5% 5-year dividend growth rate. MO yields 6.36% with 4.3% growth. The better choice depends on your goal: SCPS offers higher current income.

What is the dividend yield difference between SCPS and MO?

SCPS has a forward dividend yield of 500000.00% ($2.00/share annually). MO yields 6.36% ($4.20/share annually). The yield gap is 499993.64 percentage points.

Home › Compare › SCPS vs MO

SCPS vs MO: Dividend Comparison 2026

SCPS yields 500000.00% · MO yields 6.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SCPS wins by $4.663521010693878e+33M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SCPS

● Live price

500000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.663521010693878e+33M

Annual income

$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00

Full SCPS calculator →

Altria Group Inc.

● Live price

6.36%

Share price

$65.99

Annual div

$4.20

5Y div CAGR

22.6%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$80.1K

Annual income

$30,159.17

Full MO calculator →

Portfolio growth — SCPS vs MO

📍 SCPS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SCPS	MO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SCPS + MO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SCPS pays

MO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCPS

Annual income on $10K today (after 15% tax)

$42,500,000.00/yr

After 10yr DRIP, annual income (after tax)

$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr

Annual income on $10K today (after 15% tax)

$540.99/yr

After 10yr DRIP, annual income (after tax)

$25,635.29/yr

At 15% tax rate, SCPS beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCPS + MO for your $10,000?

SCPS: 50%MO: 50%

100% MO50/50100% SCPS

Portfolio after 10yr

$2.331760505346939e+33M

Annual income

$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.96%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

SCPS

No analyst data

Altman Z

-250.9

Piotroski

1/9

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$61.25

-7.2% upside vs current

Range: $47.00 — $68.00

Altman Z

3.2

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCPS buys

MO buys

No recent congressional trades found for SCPS or MO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSCPSMO

Forward yield	500000.00% ✓	6.36%
Annual dividend / share	$2.00	$4.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	22.6% ✓
Portfolio after 10y	$4.663521010693878e+33M	$80.1K ✓
Annual income after 10y	$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00 ✓	$30,159.17
Total dividends collected	$4.6634009849658873e+33M	$74.5K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples

Year-by-year: SCPS vs MO ($10,000, DRIP)

Year	SCPS Portfolio	SCPS Income/yr	MO Portfolio	MO Income/yr	Gap
1← crossover	$50,010,700	$50,000,000.00	$10,570	$780.30	+$50.00M → SCPS
2	$233,748,371,262	$233,694,859,813.08	$11,381	$1,032.90	+$233748.36M → SCPS
3	$1,021,074,511,412,696	$1,020,824,400,655,446.10	$12,535	$1,392.73	+$1021074511.40M → SCPS
4	$4,168,597,328,794,951,700	$4,167,504,779,067,739,000.00	$14,193	$1,920.91	+$4168597328794.94M → SCPS
5	$15,905,475,114,600,665,000,000	$15,901,014,715,458,854,000,000.00	$16,618	$2,723.68	+$15905475114600664.00M → SCPS
6	$56,718,938,532,531,060,000,000,000	$56,701,919,674,158,435,000,000,000.00	$20,263	$3,993.80	+$56718938532531060736.00M → SCPS
7	$189,031,807,435,623,860,000,000,000,000	$188,971,118,171,394,040,000,000,000,000.00	$25,936	$6,098.36	+$1.8903180743562385e+23M → SCPS
8	$588,799,810,476,518,260,000,000,000,000,000	$588,597,546,442,562,100,000,000,000,000,000.00	$35,166	$9,775.01	+$5.8879981047651824e+26M → SCPS
9	$1,714,064,268,114,722,600,000,000,000,000,000,000	$1,713,434,252,317,512,700,000,000,000,000,000,000.00	$51,026	$16,597.78	+$1.7140642681147225e+30M → SCPS
10	$4,663,521,010,693,878,300,000,000,000,000,000,000,000	$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00	$80,113	$30,159.17	+$4.663521010693878e+33M → SCPS

SCPS vs MO: Complete Analysis 2026

SCPS — Stock

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule that is an inverse agonist of the endocannabinoid system/cannabinoid receptor 1, as well as an inhibitor of inducible nitric oxide synthase. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.

Full SCPS Calculator →

MO — Consumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →

📬

Get this SCPS vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCPS vs SCHD SCPS vs JEPI SCPS vs O SCPS vs KO SCPS vs MAIN SCPS vs PM SCPS vs BTI SCPS vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.